Case Report
Marked Direct Hyperbilirubinemia due to Ceftriaxone in an Adult with Sickle Cell Disease
Table 1
Serologic evaluation of elevated direct hyperbilirubinemia.
| Serological evaluation of direct hyperbilirubinemia | Patient’s value | Normal value |
| Serum copper level | 243 | 72–166 mcg/dL | Ceruloplasmin | 59 | 15–30 mg/dL | Ferritin | 1,850 | 30–400 ng/mL | Iron | 81 | 59–159 mcg/dL | Total Iron Binding Capacity (TIBC) | 207 | 228–428 mcg/dL | Unsaturated Iron Binding Capacity (UIBC) | 126 | 112–346 mcg/dL | Iron saturation | 39 | 20–55% | Folate | 9.6 | 3.1–17.5 ng/mL | Vitamin B12 | 697 | 211–946 pg/mL | Serum zinc | 130 | 60–130 mcg/dL | Hepatitis A total | Negative | Negative | Hepatitis B core antibody IgM | Negative | Negative | Hepatitis B surface antibody | Negative | 0.0–9.9 Iunits/mL | Hepatitis B surface antigen | Negative | Negative | Hepatitis C antibody | Negative | Negative | Total IgG | 1480 | 700–1600 mg/dL | Total IgA | 376 | 70–400 mg/dL | Total IgM | 19 | 40–230 mg/dL | Antinuclear Antibody (ANA) | Negative | Negative | Mitochondrial antibody | Nondetected | Nondetected | Smooth muscle antibody | Nondetected | Nondetected |
|
|